End of treatment and 12-month post-treatment outcomes in patients treated with all-oral regimens for rifampicin-resistant tuberculosis in Ukraine: a prospective cohort study.

End of treatment and 12-month post-treatment outcomes in patients treated with all-oral regimens for rifampicin-resistant tuberculosis in Ukraine: a prospective cohort study.

The World Health Organization has called for operational research on all-oral shorter regimens for rifampin-resistant and multidrug-resistant forms of tuberculosis (RR/MDR-TB). We followed a cohort of patients in Zhytomyr, Ukraine for effectiveness, safety, tolerability and feasibility of bedaquilin...

Full description

Saved in:
Bibliographic Details
Main Authors: Vini Fardhdiani, Olena Trush, Nataliia Lytvynenko, Svitlana Pylypchuk, Yana Terleeva, Khachatur Malakyan, Praharshinie Rupasinghe, Yves Wally, Marve Duka, Vitaly Stephanovich Didyk, Olga Valentinovna Siomak, Oleksandr Blyzniuk, Jennifer Furin, Dmytro Donchuk, Chinmay Laxmeshwar, Petros Isaakidis
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2025-01-01
Series:PLOS Global Public Health
Online Access:https://doi.org/10.1371/journal.pgph.0003983
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1371/journal.pgph.0003983

Similar Items